Medical Cannabis for Older Patients
- PMID: 30488174
- DOI: 10.1007/s40266-018-0616-5
Medical Cannabis for Older Patients
Abstract
Interest in the medicinal use of cannabis and cannabinoids is mounting worldwide. Fueled by enthusiastic media coverage, patients perceive cannabinoids as a natural remedy for many symptoms. Cannabinoid use is of particular interest for older individuals who may experience symptoms such as chronic pain, sleep disturbance, cancer-related symptoms and mood disorders, all of which are often poorly controlled by current drug treatments that may also incur medication-induced side effects. This review provides a summary of the evidence for use of cannabinoids, and medical cannabis in particular, for this age group, with attention to efficacy and harms. Evidence of efficacy for relief of an array of symptoms is overall scanty, and almost all study participants are aged < 60 years. The risk of known and potential adverse effects is considerable, with concerns for cognitive, cardiovascular and gait and stability effects in older adults. Finally, in light of the paucity of clinical evidence and increasing patient requests for information or use, we propose a pragmatic clinical approach to a rational dialogue with older patients, highlighting the importance of individual benefit-risk assessment and shared patient-clinician decision making.
Similar articles
-
Medical cannabis or cannabinoids for chronic pain: a clinical practice guideline.BMJ. 2021 Sep 8;374:n2040. doi: 10.1136/bmj.n2040. BMJ. 2021. PMID: 34497062
-
Cannabis for Symptom Management in Older Adults.Med Clin North Am. 2020 May;104(3):471-489. doi: 10.1016/j.mcna.2020.01.004. Med Clin North Am. 2020. PMID: 32312410 Review.
-
Cannabis for Chronic Pain: Challenges and Considerations.Pharmacotherapy. 2018 Jun;38(6):651-662. doi: 10.1002/phar.2115. Epub 2018 May 16. Pharmacotherapy. 2018. PMID: 29637590 Review.
-
Cannabis and Cannabinoids for Chronic Pain.Curr Rheumatol Rep. 2017 Oct 5;19(11):67. doi: 10.1007/s11926-017-0693-1. Curr Rheumatol Rep. 2017. PMID: 28983880 Review.
-
Cannabinoids for Treatment of MS Symptoms: State of the Evidence.Curr Neurol Neurosci Rep. 2018 Jun 19;18(8):50. doi: 10.1007/s11910-018-0859-x. Curr Neurol Neurosci Rep. 2018. PMID: 29923025 Review.
Cited by
-
Cannabinoids in the Older Person: A Literature Review.Geriatrics (Basel). 2020 Jan 13;5(1):2. doi: 10.3390/geriatrics5010002. Geriatrics (Basel). 2020. PMID: 31941020 Free PMC article. Review.
-
Prescribed Medical Cannabis Use Among Older Individuals: Patient Characteristics and Improvements in Well-Being: Findings from T21.Drugs Aging. 2024 Jun;41(6):521-530. doi: 10.1007/s40266-024-01123-y. Epub 2024 Jun 17. Drugs Aging. 2024. PMID: 38880841
-
Cannabis Perceptions and Patterns of Use Among Older Adult Cancer Survivors.J Aging Health. 2025 Jan;37(1-2):96-105. doi: 10.1177/08982643241231320. Epub 2024 Feb 4. J Aging Health. 2025. PMID: 38311859 Free PMC article.
-
[Cannabinoids reduce opioid use in older patients with pain : Retrospective three-year analysis of data from a general practice].Schmerz. 2023 Feb;37(1):29-37. doi: 10.1007/s00482-022-00642-0. Epub 2022 Apr 6. Schmerz. 2023. PMID: 35384481 Free PMC article. German.
-
Cannabinoids as Prospective Anti-Cancer Drugs: Mechanism of Action in Healthy and Cancer Cells.Adv Exp Med Biol. 2023;1410:145-169. doi: 10.1007/5584_2022_748. Adv Exp Med Biol. 2023. PMID: 36396926
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical